Medical Services to Supply VScan Test Kits to Hospitals
Posted on: Monday, 23 January 2006, 06:00 CST
EDMONTON, Alberta, Jan. 23 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it will start to ship VScan test kits into Anhui Province in China. Medical Services has agreed to supply a private hospital in Anhui Provinc with its test kits for HIV, Hepatitis B&C, and Tuberculosis. Based on conversations with officials from the hospital, it is anticipated that this hospital will require a minimum of 500,000 to 600,000 test kits per year. Based on this agreement, our Chinese sales staff has started contacting other private facilities to set up similar arrangements elsewhere. The fact that these are private facilities means that the VScan test kits that do not as yet have regulatory approval can be used.
In regard to the Dubai health show, reports are that it is being well attended with people from all over the world. Our distributors on site have already taken orders. We are getting excellent exposure of the VScan products. Pictures of the booth at the Dubai health show will be posted on the website as soon as they are available.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or Media: Bill Whitehead,+1-416-822-5883, both for Medical Services International Inc.
Web site: http://www.medicalservicesintl.com/http://www.minerva-biotech.com/
Source: PRNewswire-FirstCall
Related Articles
- Longtop Awarded Extended Contract with a National Commercial Bank in China for Software Testing Services
- Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
- Microtest Labs Expands Clean Room, Contamination Testing Services
- Research Firm Offering Automated Testing Service to Media Outlets
- Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland Through Ireland's First Nationwide Cervical-Cancer Screening Program
- Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
- JSAT, College to Test Satellite-Based Medical Diagnosis System
- BSD Software, Inc. Announces That Its Majority Owned Subsidiary Triton Global Business Services Inc., Signs an Unlimited Applicability Statement 2 (AS2) Protocol License With Dallas Based iSoft Corporation
- FDA Scientists Testing Limits of Medical Technology
- FDA Testing Limits of Medical Technology
 |
 |
User Comments (0)
RSS Feeds